JP2024506914A5 - - Google Patents

Info

Publication number
JP2024506914A5
JP2024506914A5 JP2023548709A JP2023548709A JP2024506914A5 JP 2024506914 A5 JP2024506914 A5 JP 2024506914A5 JP 2023548709 A JP2023548709 A JP 2023548709A JP 2023548709 A JP2023548709 A JP 2023548709A JP 2024506914 A5 JP2024506914 A5 JP 2024506914A5
Authority
JP
Japan
Prior art keywords
therapeutic composition
cancer
composition according
inhibitor
cancer cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023548709A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506914A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/016161 external-priority patent/WO2022174064A2/en
Publication of JP2024506914A publication Critical patent/JP2024506914A/ja
Publication of JP2024506914A5 publication Critical patent/JP2024506914A5/ja
Pending legal-status Critical Current

Links

JP2023548709A 2021-02-12 2022-02-11 がんの処置のための多重免疫療法とがんワクチンとを組み合わせた治療用組成物及び方法 Pending JP2024506914A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163148922P 2021-02-12 2021-02-12
US63/148,922 2021-02-12
PCT/US2022/016161 WO2022174064A2 (en) 2021-02-12 2022-02-11 Therapeutic composition and method combining multiplex immunotherapy with cancer vaccine for the treatment of cancer

Publications (2)

Publication Number Publication Date
JP2024506914A JP2024506914A (ja) 2024-02-15
JP2024506914A5 true JP2024506914A5 (https=) 2025-02-20

Family

ID=80448388

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023548709A Pending JP2024506914A (ja) 2021-02-12 2022-02-11 がんの処置のための多重免疫療法とがんワクチンとを組み合わせた治療用組成物及び方法

Country Status (9)

Country Link
US (2) US12263219B2 (https=)
EP (1) EP4291168A2 (https=)
JP (1) JP2024506914A (https=)
KR (1) KR20230145407A (https=)
AU (1) AU2022220325A1 (https=)
BR (1) BR112023016320A2 (https=)
CA (1) CA3208059A1 (https=)
IL (1) IL305126A (https=)
WO (1) WO2022174064A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015085162A1 (en) 2013-12-05 2015-06-11 Rfemb Holdings, Llc Cancer immunotherapy by radiofrequency electrical membrane breakdown (rf-emb)
KR20180108655A (ko) * 2016-01-15 2018-10-04 알에프이엠비 홀딩스, 엘엘씨 암의 면역학적 치료
WO2024058504A1 (ko) * 2022-09-16 2024-03-21 (주)한국원자력 엔지니어링 앱스코팔 효과를 갖는, 암의 예방 또는 치료용 조성물 및 이를 이용한 암의 예방 또는 치료방법
KR102872574B1 (ko) * 2022-10-27 2025-10-17 이화여자대학교 산학협력단 저출력의 가시광선으로 항종양 면역을 강화하는 광역학 치료용 이식형 마이크로-발광 다이오드 장치 및 이의 작동방법
CN117815386B (zh) * 2024-01-05 2025-02-14 北京大学第三医院 一种淋巴结靶向的肿瘤原位疫苗及其制备方法和应用

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785806A (en) 1987-01-08 1988-11-22 Yale University Laser ablation process and apparatus
US4945912A (en) 1988-11-25 1990-08-07 Sensor Electronics, Inc. Catheter with radiofrequency heating applicator
US5383917A (en) 1991-07-05 1995-01-24 Jawahar M. Desai Device and method for multi-phase radio-frequency ablation
US20040002647A1 (en) 1991-10-18 2004-01-01 Ashvin Desai Gel injection treatment of body parts
DE69224911T2 (de) 1991-11-04 1998-12-03 Baxter International Inc., Deerfield, Ill. 60015 Ultraschallgerät zur ablation mit kanal für führungsdraht
US5524620A (en) 1991-11-12 1996-06-11 November Technologies Ltd. Ablation of blood thrombi by means of acoustic energy
US5231047A (en) 1991-12-19 1993-07-27 Energy Conversion Devices, Inc. High quality photovoltaic semiconductor material and laser ablation method of fabrication same
US5540681A (en) 1992-04-10 1996-07-30 Medtronic Cardiorhythm Method and system for radiofrequency ablation of tissue
US5573533A (en) 1992-04-10 1996-11-12 Medtronic Cardiorhythm Method and system for radiofrequency ablation of cardiac tissue
US5487740A (en) 1994-03-02 1996-01-30 Energy Life Systems Corporation Laser device for ablation of human tissue
US6813520B2 (en) 1996-04-12 2004-11-02 Novacept Method for ablating and/or coagulating tissue using moisture transport
US5800487A (en) 1996-07-23 1998-09-01 Endocare, Inc. Cryoprobe
US7220257B1 (en) 2000-07-25 2007-05-22 Scimed Life Systems, Inc. Cryotreatment device and method
US6132424A (en) 1998-03-13 2000-10-17 Lasersight Technologies Inc. Smooth and uniform laser ablation apparatus and method
US7001378B2 (en) 1998-03-31 2006-02-21 Innercool Therapies, Inc. Method and device for performing cooling or cryo-therapies, for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection
FR2778573B1 (fr) 1998-05-13 2000-09-22 Technomed Medical Systems Reglage de frequence dans un appareil de traitement par ultrasons focalises de haute intensite
US20050255039A1 (en) 1998-06-26 2005-11-17 Pro Surg, Inc., A California Corporation Gel injection treatment of breast, fibroids & endometrial ablation
US6428968B1 (en) 1999-03-15 2002-08-06 The Trustees Of The University Of Pennsylvania Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject
US7226446B1 (en) 1999-05-04 2007-06-05 Dinesh Mody Surgical microwave ablation assembly
US6325796B1 (en) 1999-05-04 2001-12-04 Afx, Inc. Microwave ablation instrument with insertion probe
US6306132B1 (en) 1999-06-17 2001-10-23 Vivant Medical Modular biopsy and microwave ablation needle delivery apparatus adapted to in situ assembly and method of use
US7033352B1 (en) 2000-01-18 2006-04-25 Afx, Inc. Flexible ablation instrument
US7706882B2 (en) 2000-01-19 2010-04-27 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area
US6595934B1 (en) 2000-01-19 2003-07-22 Medtronic Xomed, Inc. Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6471696B1 (en) 2000-04-12 2002-10-29 Afx, Inc. Microwave ablation instrument with a directional radiation pattern
US6932814B2 (en) 2000-07-10 2005-08-23 The United States Of America As Represented By The Department Of Health And Human Services Radiofrequency probes for tissue treatment and methods of use
US6811562B1 (en) 2000-07-31 2004-11-02 Epicor, Inc. Procedures for photodynamic cardiac ablation therapy and devices for those procedures
US6821274B2 (en) 2001-03-07 2004-11-23 Gendel Ltd. Ultrasound therapy for selective cell ablation
US6648880B2 (en) 2001-02-16 2003-11-18 Cryocath Technologies Inc. Method of using cryotreatment to treat brain tissue
US20030065317A1 (en) 2001-09-19 2003-04-03 Rudie Eric N. Microwave ablation device
CA2461217A1 (en) 2001-09-27 2003-04-03 Roni Zvuloni Cryoplasty apparatus and method
US6579287B2 (en) 2001-10-09 2003-06-17 Cryocath Technologies Inc. Cryosurgical ablation device having sequential injection and method therefor
US8974446B2 (en) 2001-10-11 2015-03-10 St. Jude Medical, Inc. Ultrasound ablation apparatus with discrete staggered ablation zones
AU2003284285A1 (en) 2002-10-17 2004-05-04 Pro Surg, Inc. Gel injection apparatus and treatment of breast, fibroids and endometrial ablation
JP2007527728A (ja) 2003-04-03 2007-10-04 ガリル メディカル リミテッド 正確に画定された冷凍切除のための装置及び方法
US7311701B2 (en) 2003-06-10 2007-12-25 Cierra, Inc. Methods and apparatus for non-invasively treating atrial fibrillation using high intensity focused ultrasound
US7670335B2 (en) 2003-07-21 2010-03-02 Biosense Webster, Inc. Ablation device with spiral array ultrasound transducer
EP1696812B1 (en) 2003-12-24 2015-07-22 The Regents of The University of California Tissue ablation with irreversible electroporation
US20060052706A1 (en) 2004-08-20 2006-03-09 Kullervo Hynynen Phased array ultrasound for cardiac ablation
US20060056480A1 (en) 2004-09-15 2006-03-16 Mielke Michael M Actively stabilized systems for the generation of ultrashort optical pulses
US8420078B2 (en) 2005-03-10 2013-04-16 Yeda Research And Development Co. Ltd. Methods and immunogenic cell preparations for treating antigen-associated diseases
US20070129712A1 (en) 2005-12-01 2007-06-07 Ceramoptec Industries, Inc. Benign prostate hyperplasia treatment using photosensitizer and laser ablation
ES2551306T3 (es) 2006-02-13 2015-11-17 Oncolytics Biotech Inc. Uso de inmunosupresión local de baja dosis para potenciar una terapia viral oncolítica
US20080039746A1 (en) 2006-05-25 2008-02-14 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US20090000184A1 (en) 2006-07-21 2009-01-01 Garwood Anthony J Method of processing bio-mass matter into renewable fluid fuels (synthetic diesel)
WO2008021321A2 (en) 2006-08-17 2008-02-21 Rjf Holdings Iv, Inc Method and apparatus for plasma incision of cardiovascular tissue
US9320794B2 (en) * 2006-11-13 2016-04-26 Immunovative Therapies, Ltd. Ablative immunotherapy
US8152801B2 (en) 2006-12-06 2012-04-10 Boston Scientific Scimed, Inc. Tissue ablation using pulse modulated radio frequency energy
US20100178684A1 (en) 2006-12-21 2010-07-15 Woo Savio L C Transgenic oncolytic viruses and uses thereof
US7655004B2 (en) 2007-02-15 2010-02-02 Ethicon Endo-Surgery, Inc. Electroporation ablation apparatus, system, and method
AU2008219461B2 (en) 2007-02-27 2013-10-03 Regents Of The University Of Minnesota Thermochemical ablation of bodily tissue
WO2008108980A2 (en) 2007-03-01 2008-09-12 Nanospectra Biosciences, Inc. Devices and methods for extracorporeal ablation of circulating cells
WO2008142686A2 (en) 2007-05-21 2008-11-27 Uc-Care Ltd. Ablation probe
JP4635233B2 (ja) 2007-09-06 2011-02-23 株式会社ハイレックスコーポレーション 衝撃波アブレーションシステム
WO2009082433A2 (en) 2007-12-05 2009-07-02 Reset Medical, Inc Method for cryospray ablation
US7996078B2 (en) 2007-12-31 2011-08-09 St. Jude Medical, Atrial Fibrillation Division, Inc. Systems and methods of photodynamic-based cardiac ablation via the esophagus
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US8221411B2 (en) 2008-07-28 2012-07-17 Medtronic, Inc. Systems and methods for cardiac tissue electroporation ablation
WO2010118387A1 (en) 2009-04-09 2010-10-14 Virginia Tech Intellectual Properties, Inc. Integration of very short electric pulses for minimally to noninvasive electroporation
DK3117784T3 (en) 2009-07-08 2019-04-08 Sanuwave Inc USE OF INTRACORPORAL PRESSURE SHOCK WAVES IN MEDICINE
AU2010324908B2 (en) 2009-11-24 2014-05-15 Regents Of The University Of Minnesota Methods and systems for chemical ablation
US8690866B2 (en) 2010-08-23 2014-04-08 Covidien Lp Ablation devices utilizing exothermic chemical reactions, system including same, and methods of ablating tissue using same
EP2642937A4 (en) 2010-11-23 2014-05-07 Virginia Tech Intell Prop IRREVERSIBLE ELECTROPORATION USING TISSUE BLOOD VESSELS FOR THE TREATMENT OF BUTTERED CELL MASS OR FOR THE PRODUCTION OF TISSUE OBSTACLES
WO2012088149A2 (en) 2010-12-20 2012-06-28 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
WO2012158530A1 (en) 2011-05-13 2012-11-22 Broncus Technologies, Inc. Methods and devices for ablation of tissue
US9204918B2 (en) 2011-09-28 2015-12-08 RELIGN Corporation Medical ablation system and method of use
CA2856732A1 (en) 2011-12-09 2013-06-13 Metavention, Inc. Therapeutic neuromodulation of the hepatic system
US10537375B2 (en) 2015-04-24 2020-01-21 Neurotronic, Inc. Chemical ablation and method of treatment for various diseases
EP4464374A3 (en) 2012-11-02 2025-01-15 Neurotronic, Inc. Chemical ablation formulations for various diseases
US10154869B2 (en) 2013-08-02 2018-12-18 Gary M. Onik System and method for creating radio-frequency energy electrical membrane breakdown for tissue ablation
WO2015085162A1 (en) 2013-12-05 2015-06-11 Rfemb Holdings, Llc Cancer immunotherapy by radiofrequency electrical membrane breakdown (rf-emb)
EP3137105A4 (en) * 2014-04-30 2017-12-27 President and Fellows of Harvard College Combination vaccine devices and methods of killing cancer cells
US10023858B2 (en) 2014-05-29 2018-07-17 U.S. Patent Innovations, LLC System and method for selective ablation of cancer cells with cold atmospheric plasma
US10376674B2 (en) 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
US11141216B2 (en) 2015-01-30 2021-10-12 Immunsys, Inc. Radio-frequency electrical membrane breakdown for the treatment of high risk and recurrent prostate cancer, unresectable pancreatic cancer, tumors of the breast, melanoma or other skin malignancies, sarcoma, soft tissue tumors, ductal carcinoma, neoplasia, and intra and extra luminal abnormal tissue
US20180028267A1 (en) 2015-02-04 2018-02-01 Rfemb Holdings, Llc Radio-frequency electrical membrane breakdown for the treatment of benign prostatic hyperplasia
US20180028260A1 (en) 2015-02-04 2018-02-01 Rfemb Holdings, Llc Radio-frequency electrical membrane breakdown for the treatment of adipose tissue and removal of unwanted body fat
CA2975938A1 (en) 2015-02-04 2016-08-11 Rfemb Holdings, Llc Radio-frequency electrical membrane breakdown for reducing restenosis
US20180028264A1 (en) 2015-02-06 2018-02-01 Rfemb Holdings, Llc Radio-frequency electrical membrane breakdown for the treatment of cardiac rhythm disorders and for renal neuromodulation
AU2016220549B2 (en) 2015-02-17 2021-09-23 Nanyang Technological University Regenerable draw solute for osmotically driven processes
KR20180108655A (ko) 2016-01-15 2018-10-04 알에프이엠비 홀딩스, 엘엘씨 암의 면역학적 치료
BR112021017691A2 (pt) * 2019-03-06 2022-01-04 Univ Chile Formulações imunogênicas para o tratamento do câncer
US20210154281A1 (en) * 2019-11-26 2021-05-27 Massachusetts Institute Of Technology Cell-based cancer vaccines and cancer therapies

Similar Documents

Publication Publication Date Title
JP2024506914A5 (https=)
US20230149525A1 (en) Immunogenic treatment of cancer
Agarwal et al. Therapeutic options in vitiligo with special emphasis on immunomodulators: A comprehensive update with review of literature
CZ31696A3 (en) The use of triphenylethylene antiestrogens for increasing sensitivity of cancer cells for lysis mediated through killing cells
Knobler Current management strategies for cutaneous T-cell lymphoma
JP2011506467A (ja) 抗悪性腫瘍性熱ショックアポトーシス活性化因子(hsaa)と組み合わせられたアルファチモシンペプチドによる黒色腫の処置の方法
Korobko Review of current clinical studies of vitiligo treatments
Sotiriou et al. Etanercept for the treatment of hidradenitis suppurativa
CN115463118A (zh) 和厚朴酚在制备治疗或预防毛细血管瘤的药物中的用途
Bassiony et al. Immunotherapy and cancer
WO2018069536A1 (en) Treatment of cholangiocarcinoma with tpcs-2a induced photochemical internalisation of gemcitabine
RU2524309C1 (ru) Способ выбора тактики лечения местно-распространенного рака предстательной железы
US20040001847A1 (en) Method and composition to elicit an effective autologous antitumoral immune response in a patient
Leżanko et al. Vitiligo treatment: a literature review
Digra et al. Autologous Whole-Blood Versus Corticosteroid Local Injection in Treatment of Plantar Fasciitis: A Randomized Single Blind Placebo-Controlled Study
US20240108704A1 (en) Compositions, systems, and methods for treating cancer using alternating electric fields and apoptotic cancer cell vaccination
Białczyk et al. Abscopal effect in solid tumors. Potential mechanisms, application of radioimmunotherapy, and a review of exemplary clinical cases
RU2741711C1 (ru) Способ лечения больных раком с метастазами
KR20210039414A (ko) 암의 치료를 위한 병용 요법
RU2530523C2 (ru) Способ противоопухолевой иммунотерапии
Mohammed et al. A review of the literature on intra-lesional immunotherapeutic intervention for the treatment of recalcitrant warts
RU2316295C1 (ru) Способ консервативного лечения гемангиомы придаточного аппарата глаза и орбиты у детей
US20190239937A1 (en) Augmentation of Abscopal Effect of Cryotherapy and other Tumor Cell Death by Anti-angiogenic and Anti-tumor Vaccination
RU2401671C1 (ru) Способ лечения т-клеточных лимфом и саркомы капоши
RU2147440C1 (ru) Обезболивающее и противозудное средство